The chief executive of health watchdog Nice told ITV News he is "disappointed" that drug manufacturer Roche has not offered the NHS a discount on a breast cancer drug that costs around £90,000 per patient.
Kadcyla, which extends women's lives by almost six months, could be blocked from routine NHS access because it is too expensive.
"Companies can discount their prices and they frequently do. Given the list price. I would have expected the company to have at least considered (a discount)," Andrew Dillon said.
More top news
Durrell Wildlife Conservation Trust in Jersey is urging people to stop using palm oil products to help save endangered orangutans.
AlphaBay, where illegal items including drugs were traded, is one of two dark web markets seized after an US and Europe-led operation.
Sir Vince Cable has become the new leader of the Liberal Democrats, after no other nominations were put forward.